Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates

Nov 2, 2021 · Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $926 million or $3.56 per share for the period. Analysts had expected the company to earn $3.08 …

$926
OFF

Vertex Pharmaceuticals Inc. Q3 Adjusted Earnings Beat Estimates

2 weeks from now

Nov 2, 2021 · Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $926 million or $3.56 per share for the period. Analysts had expected the company to earn $3.08 …

nasdaq.com

$4.38
OFF

VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, surpassing the Zacks Consensus Estimate of $4.13. In …

yahoo.com

$1.14
OFF

Vertex Pharmaceuticals Inc. Q3 Profit Increases, Beats Estimates

2 weeks from now

Nov 4, 2024 · Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.143 billion or $4.38 per share for the period. Analysts on average had expected the company to …

nasdaq.com

$3.97
OFF

Vertex (VRTX) Q3 Earnings Beat, Sales Miss, Raises '23 View

2 weeks from now

Nov 7, 2023 · Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings per share (EPS) of $3.97 in third-quarter 2023, beating the Zacks Consensus Estimate of $3.92.The …

yahoo.com

$4.08
OFF

Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings Estimates

2 weeks from now

Nov 6, 2023 · Vertex Pharmaceuticals (VRTX Quick Quote VRTX - Free Report) came out with quarterly earnings of $4.08 per share, beating the Zacks Consensus Estimate of $3.92 per …

zacks.com

05%
OFF

Vertex Pharmaceuticals Q3 Earnings Beat Estimates - VRTX

2 weeks from now

Vertex Pharmaceuticals (VRTX) reported Q3 earnings of $4.38 per share, surpassing the Zacks Consensus Estimate of $4.13 and reflecting a 6.05% earnings surprise. Revenues for the …

investingsnacks.com

$4.38
OFF

Vertex Pharmaceuticals Tops Q3 Estimates | The Motley Fool

2 weeks from now

Nov 4, 2024 · Vertex Pharmaceuticals Tops Q3 Estimates . By JesterAI – Updated Nov 4, 2024 at 6:24PM Key Points ... Non-GAAP earnings per share of $4.38 beat analyst estimates of $4.08.

fool.com

$3.56
OFF

Vertex (VRTX) Beats On Q3 Earnings & Sales, Raises '21 View

2 weeks from now

Nov 3, 2021 · Vertex Pharmaceuticals Incorporated VRTX reported third-quarter 2021 adjusted earnings per share of $3.56, which beat the Zacks Consensus Estimate of $3.12.Earnings …

yahoo.com

7%
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect

2 weeks from now

3 days ago · However, shares rose 5.7% following its strong Q3 earnings release on Nov. 4. The company reported revenue of $2.77 billion, up 11.7% year-over-year, exceeding Wall Street …

nasdaq.com

$4.38
OFF

Vertex Pharmaceuticals (VRTX) Q3 Earnings And Revenues Top …

2 weeks from now

Nov 4, 2024 · Vertex Pharmaceuticals (VRTX Quick Quote VRTX - Free Report) came out with quarterly earnings of $4.38 per share, beating the Zacks Consensus Estimate of $4.13 per …

zacks.com

$3.41
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect

2 weeks from now

3 days ago · The company is set to release its Q4 earnings on Wednesday, Feb. 3. Ahead of the event, analysts expect Vertex to report a profit of $3.41 per share on a diluted basis, down …

tradingview.com

$3.41
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect - Inkl

2 weeks from now

4 days ago · The company is set to release its Q4 earnings on Wednesday, Feb. 3. Ahead of the event, analysts expect Vertex to report a profit of $3.41 per share on a diluted basis, down …

inkl.com

$2.77
OFF

Vertex (VRTX) Q3 Earnings: Taking A Look At Key Metrics Versus …

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals (VRTX Quick Quote VRTX - Free Report) reported $2.77 billion in revenue for the quarter ended September 2024, representing a year-over-year …

zacks.com

7%
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect - MSN

2 weeks from now

However, shares rose 5.7% following its strong Q3 earnings release on Nov. 4. The company reported revenue of $2.77 billion, up 11.7% year-over-year, exceeding Wall Street estimates of …

msn.com

6%
OFF

Vertex (VRTX) Q3 Earnings: Taking A Look At Key Metrics Versus …

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals (VRTX) reported $2.77 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 11.6%. EPS of $4.38 for …

yahoo.com

2%
OFF

Q3 Earnings Highs And Lows: IPG Photonics (NASDAQ:IPGP) Vs …

2 weeks from now

3 days ago · The 14 semiconductor manufacturing stocks we track reported a satisfactory Q3. As a group, revenues beat analysts’ consensus estimates by 2% while next quarter’s revenue …

yahoo.com

FAQs about Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates Coupon?

How much did Vertex Pharmaceuticals make in the third quarter?

The company's bottom line came in at $1.045 billion, or $4.01 per share. This compares with $1.035 billion, or $3.97 per share, in last year's third quarter. Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.143 billion or $4.38 per share for the period. ...

How much did Vertex Pharmaceuticals (VRTX) earnings beat analysts' estimate?

In the previous quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) reported $4.76 earnings per share (EPS) to beat the analysts' consensus estimate of $3.66 by $1.10. Learn more on analysts' earnings estimate vs. VRTX's actual earnings. How can I listen to Vertex Pharmaceuticals's earnings conference call? ...

When is vertex releasing Q4 earnings?

The company is set to release its Q4 earnings on Wednesday, Feb. 3. Ahead of the event, analysts expect Vertex to report a profit of $3.41 per share on a diluted basis, down 4.5% from $3.57 per share in the year-ago quarter. The company beat the consensus estimates in two of the last four quarters while missing on two other occasions. ...

When is Vertex Pharmaceuticals' next earnings release date?

Vertex Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on VRTX's earnings history. Did Vertex Pharmaceuticals beat their earnings estimates last quarter? ...

What did Vertex Pharmaceuticals (VRTX) report?

Vertex Pharmaceuticals (VRTX 0.36%), a leader in cystic fibrosis treatments, released its third-quarter results on Nov. 4. The report highlighted significant growth, with revenue reaching $2.77 billion compared to analysts' consensus estimate of $2.69 billion. Vertex reported non-GAAP earnings per share of $4.38; analysts had expected $4.08. ...

How much revenue does vertex make a year?

The company reported revenue of $2.77 billion, up 11.7% year-over-year, exceeding Wall Street estimates of $2.67 billion. Additionally, Vertex raised its full-year product revenue guidance to a range of $10.8 billion to $10.9 billion. ...